Because these medications can reduce overall systemic inflammation, they also reduce the presence of advanced glycation end products (AGEs), which are linked to yellowing or browning of the skin, wrinkling, or sagging
Recent evidence from the STEP-HFpEF and STEP-HFpEF-DM trials provides the first robust data supporting the efficacy of GLP-1 RAs, specifically semaglutide, in improving the quality of life in obese patients with HFpEF
Many people on these medications find they naturally drink less without trying to
Hwang HT, Qi F, Yuan C, Zhao X, Ramkrishna D, Liu D et al (2014) Lipase-catalyzed process for biodiesel production: protein engineering and lipase production
10.1007/s10741-020-10003-7 102 ElliottW